Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of Patients with Risk Factors: Compliance and Adherence

Treatment of Patients with Risk Factors: Compliance and Adherence References1. World Health Organisation. World health statistics 2013; 2013. Available from: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2013_Full.pdf.2. Eurostat Press Office. Europe in figures – Eurostat yearbook 2012 A gateway to European statistics; 2012 May 11. Available from: http://europa.eu/rapid/press-release_STAT-12-70_en.htm?locale=en.3. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. WHO Library Cataloguing-in-Publication Data; 2009.4. Lindsay P, Bayley M, Hellings C et al. Canadian Stroke Strategy Best Practices and Standards Writing Group on behalf of the Canadian Stroke Strategy, a joint initiative of the Canadian Stroke Network and the Heart and Stroke Foundation of Canada. Canadian best practice recommendations for stroke care (updated 2008). CMAJ 2008; 179:E1–E93. https://doi.org/10.1503/cmaj.081148.R25. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364:937-52. https://doi.org/10.1016/S0140-6736(04)17018-96. Radenković S. Rezistentna arterijska hipertenzija : etiopatogenetski, dijagnostički i terapijski karakteri. 1. izd. Medicinski fakultet, Punta, Niš, 2013: 219.7. Reiner Z, Catapano A, De Backer G et al. ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2011; 32: 1769–818. https://doi.org/10.1093/eurheartj/ehr1588. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Brit Med Bull 1994; 50: 272–98.9. Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: 1903-13. https://doi.org/10.1016/S0140-6736(02)11911-810. Fretheim A, Odgaard-Jensen J, Brors O et al. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: Systematic review and multiple treatments meta-analysis. BMC Medicine 2012; 10:33. https://doi.org/10.1186/1741-7015-10-3311. Accetto R, Dobovišek J, Dolenc P et al. Slovenske smernice za obravnavo arterijske hipertenzije (2003). Zdrav Vestn 2004; 73: 507–17.12. Petek-Šter M, Švab I. Nadzor krvnega tlaka pri bolnikih z arterijsko hipertenzijo v Sloveniji. (Blood pressure control in patients with arterial hypertension in Slovenia). Zdrav Vestn 2007; 76: 397–403.13. Giannattasio C, Cairo M, Cesana F et al. Blood pressure control in Italian Essential Hypertensives Treated by General practitioners. Am J Hypertens 2012; 25: 1182–7. https://doi.org/10.1038/ajh.2012.10814. Accetto R, Salobir B. Epidemiološka raziskava hipertenzije v Sloveniji delno poročilo. V: Dolenc P, ur. XVIII. Strokovni sestanek Sekcije za arterijsko hipertenzijo. Zbornik. Portorož, 26.-27. november 2009. Sekcija za arterijsko hipertenzijo, Ljubljana, 2009: 9–18.15. Studies P, Lewington S, Whitlock G et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 2007; 370:1829–1839. https://doi.org/10.1016/S0140-6736(07)61778-416. Fras Z, Jug B. Pregled in poudarki ESC/EAS smernic za obravnavo dislipidemij 2011. Slovenski forum za preventivo bolezni srca in žilja 2012. Zbornik, Ljubljana, 2012.17. Kotsev K, Woo D, De Bacque D et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Card2016;23:636-48. https://doi.org/10.1177/204748731556940118. Jones PH, Nair R, Thakker KM. Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin-Treated Subjects From 3 Data Sources: A Retrospective Analysis. J Am Heart Ass 2012;1. https://doi.org/10.1161/jaha.112.00180019. Brookes L. ASCOT: Anglo Scandinavian Cardiac Outcomes Trial. Medscape. Oct 04, 2005. Available from: http://www.medscape.com/viewarticle/51397420. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7–22. https://doi.org/10.1016/S0140-6736(02)09327-321. Gupta AK, Arshad S, Poulter NR. Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents. A Meta-Analysis. Hypertension 2010; 55:399–407. https://doi.org/10.1161/HYPERTENSIONAHA.109.13981622. Bangalore S, Kamalakkannan G, Parkar S et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120:713–9. https://doi.org/10.1016/j.amjmed.2006.08.03323. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19:1190–6. https://doi.org/10.1016/j.amjhyper.2006.04.00624. Sherrill B, Halpern M, Khan S et al. Single-Pill vs Free-Equivalent Combination Therapies for Hypertension: A Meta-Analysis of Health Care Costs and Adherence. J Clin Hypertens 2011; 13: 898–909. https://doi.org/10.1111/j.1751-7176.2011.00550.x25. Benner JS, Glynn RJ, Mogun H et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288:455–61. https://doi.org/10.1001/jama.288.4.45526. Chapman R, Benner J, Petrilla AA et al. Predictors of adherence with Antihypertensive and lipid-lowering therapy. Value in Health 2004; 7:319. https://doi.org/10.1016/S1098-3015(10)62371-627. Dobovišek J. Zdravljenje arterijske hipertenzije. Obzornik zdravstvene nege 1977;11: 21–8. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Facultatis Medicae Naissensis de Gruyter

Treatment of Patients with Risk Factors: Compliance and Adherence

Download PDF
7 pages

Loading next page...
 
/lp/de-gruyter/treatment-of-patients-with-risk-factors-compliance-and-adherence-Wd00yeIfKC
Publisher
de Gruyter
Copyright
© 2017 Acta Facultatis Medicae Naissensis
ISSN
2217-2521
eISSN
2217-2521
DOI
10.1515/afmnai-2017-0001
Publisher site
See Article on Publisher Site

Abstract

References1. World Health Organisation. World health statistics 2013; 2013. Available from: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2013_Full.pdf.2. Eurostat Press Office. Europe in figures – Eurostat yearbook 2012 A gateway to European statistics; 2012 May 11. Available from: http://europa.eu/rapid/press-release_STAT-12-70_en.htm?locale=en.3. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. WHO Library Cataloguing-in-Publication Data; 2009.4. Lindsay P, Bayley M, Hellings C et al. Canadian Stroke Strategy Best Practices and Standards Writing Group on behalf of the Canadian Stroke Strategy, a joint initiative of the Canadian Stroke Network and the Heart and Stroke Foundation of Canada. Canadian best practice recommendations for stroke care (updated 2008). CMAJ 2008; 179:E1–E93. https://doi.org/10.1503/cmaj.081148.R25. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364:937-52. https://doi.org/10.1016/S0140-6736(04)17018-96. Radenković S. Rezistentna arterijska hipertenzija : etiopatogenetski, dijagnostički i terapijski karakteri. 1. izd. Medicinski fakultet, Punta, Niš, 2013: 219.7. Reiner Z, Catapano A, De Backer G et al. ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2011; 32: 1769–818. https://doi.org/10.1093/eurheartj/ehr1588. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Brit Med Bull 1994; 50: 272–98.9. Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: 1903-13. https://doi.org/10.1016/S0140-6736(02)11911-810. Fretheim A, Odgaard-Jensen J, Brors O et al. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: Systematic review and multiple treatments meta-analysis. BMC Medicine 2012; 10:33. https://doi.org/10.1186/1741-7015-10-3311. Accetto R, Dobovišek J, Dolenc P et al. Slovenske smernice za obravnavo arterijske hipertenzije (2003). Zdrav Vestn 2004; 73: 507–17.12. Petek-Šter M, Švab I. Nadzor krvnega tlaka pri bolnikih z arterijsko hipertenzijo v Sloveniji. (Blood pressure control in patients with arterial hypertension in Slovenia). Zdrav Vestn 2007; 76: 397–403.13. Giannattasio C, Cairo M, Cesana F et al. Blood pressure control in Italian Essential Hypertensives Treated by General practitioners. Am J Hypertens 2012; 25: 1182–7. https://doi.org/10.1038/ajh.2012.10814. Accetto R, Salobir B. Epidemiološka raziskava hipertenzije v Sloveniji delno poročilo. V: Dolenc P, ur. XVIII. Strokovni sestanek Sekcije za arterijsko hipertenzijo. Zbornik. Portorož, 26.-27. november 2009. Sekcija za arterijsko hipertenzijo, Ljubljana, 2009: 9–18.15. Studies P, Lewington S, Whitlock G et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 2007; 370:1829–1839. https://doi.org/10.1016/S0140-6736(07)61778-416. Fras Z, Jug B. Pregled in poudarki ESC/EAS smernic za obravnavo dislipidemij 2011. Slovenski forum za preventivo bolezni srca in žilja 2012. Zbornik, Ljubljana, 2012.17. Kotsev K, Woo D, De Bacque D et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Card2016;23:636-48. https://doi.org/10.1177/204748731556940118. Jones PH, Nair R, Thakker KM. Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin-Treated Subjects From 3 Data Sources: A Retrospective Analysis. J Am Heart Ass 2012;1. https://doi.org/10.1161/jaha.112.00180019. Brookes L. ASCOT: Anglo Scandinavian Cardiac Outcomes Trial. Medscape. Oct 04, 2005. Available from: http://www.medscape.com/viewarticle/51397420. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7–22. https://doi.org/10.1016/S0140-6736(02)09327-321. Gupta AK, Arshad S, Poulter NR. Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents. A Meta-Analysis. Hypertension 2010; 55:399–407. https://doi.org/10.1161/HYPERTENSIONAHA.109.13981622. Bangalore S, Kamalakkannan G, Parkar S et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120:713–9. https://doi.org/10.1016/j.amjmed.2006.08.03323. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19:1190–6. https://doi.org/10.1016/j.amjhyper.2006.04.00624. Sherrill B, Halpern M, Khan S et al. Single-Pill vs Free-Equivalent Combination Therapies for Hypertension: A Meta-Analysis of Health Care Costs and Adherence. J Clin Hypertens 2011; 13: 898–909. https://doi.org/10.1111/j.1751-7176.2011.00550.x25. Benner JS, Glynn RJ, Mogun H et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288:455–61. https://doi.org/10.1001/jama.288.4.45526. Chapman R, Benner J, Petrilla AA et al. Predictors of adherence with Antihypertensive and lipid-lowering therapy. Value in Health 2004; 7:319. https://doi.org/10.1016/S1098-3015(10)62371-627. Dobovišek J. Zdravljenje arterijske hipertenzije. Obzornik zdravstvene nege 1977;11: 21–8.

Journal

Acta Facultatis Medicae Naissensis – de Gruyter

Published: Mar 1, 2017

References

  • Single - Pill vs Free - Equivalent Combination Therapies for Hypertension A Meta - Analysis of Health Care Costs and Adherence https doi org
    Sherrill
  • Fixed - dose combinations improve medication compliance : a meta - analysis https doi org
    Bangalore
  • Age - specific relevance of usual blood pressure to vascular mortality A meta - analysis of individual data for one million adults in prospective studies https doi org
    Lewington
  • Petek Nadzor krvnega tlaka pri bolnikih z arterijsko hipertenzijo v Sloveniji ( Blood pressure control in patients with arterial hypertension in Slovenia )
    Šter
  • Long - term persistence in use of statin therapy in elderly patients https doi org
    Benner
  • EUROASPIRE IV A European Society of Cardiology survey on the lifestyle , risk factor and therapeutic management of coronary patients from European countries https doi org
    Kotsev
  • Predictors of adherence with Antihypertensive and lipid - lowering therapy Value in https doi org
    Chapman
  • Slovenske smernice za obravnavo arterijske hipertenzije (
    Accetto
  • Compliance Safety and Effectiveness of Fixed - Dose Combinations of Antihypertensive Agents A Meta - Analysis https doi org
    Gupta
  • Blood cholesterol and vascular mortality by age sex and blood pressure A meta - analysis of individual data from prospective studies with vascular deaths https doi org
    Studies
  • Blood pressure , antihypertensive drug treatment and the risks of stroke and of coronary heart disease
    Collins
  • Effect of potentially modifiable risk factors associated with myocardial infarction in countries ( the INTERHEART study ) : Case - control study https doi org
    Yusuf
  • ESC EAS Guidelines for the management of dyslipidaemias https doi org
    Reiner
  • Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin - Treated Subjects From Data Sources A Retrospective Analysis https doi org
    Jones
  • Medication adherence and persistence as the cornerstone of effective antihypertensive therapy https doi org
    Burnier
  • Blood pressure control in Italian Essential Hypertensives Treated by General practitioners https doi org
    Giannattasio
  • Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease : Systematic review and multiple treatments meta - analysis https doi org
    Fretheim